98 related articles for article (PubMed ID: 15149642)
1. Synthesis and pharmacological evaluation of piperidinoalkanoyl-1,2,3,4-tetrahydroisoquinoline derivatives as novel specific bradycardic agents.
Kubota H; Watanabe T; Kakefuda A; Masuda N; Wada K; Ishii N; Sakamoto S; Tsukamoto S
Bioorg Med Chem Lett; 2004 Jun; 14(12):3049-52. PubMed ID: 15149642
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological evaluation of N-acyl-1,2,3,4-tetrahydroisoquinoline derivatives as novel specific bradycardic agents.
Kubota H; Watanabe T; Kakefuda A; Masuda N; Wada K; Ishii N; Sakamoto S; Tsukamoto S
Bioorg Med Chem; 2004 Mar; 12(5):871-82. PubMed ID: 14980599
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological evaluation of 2-(3-piperidyl)-1,2,3,4-tetrahydroisoquinoline derivatives as specific bradycardic agents.
Kakefuda A; Watanabe T; Taguchi Y; Masuda N; Tanaka A; Yanagisawa I
Chem Pharm Bull (Tokyo); 2003 Apr; 51(4):390-8. PubMed ID: 12672990
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacological evaluation of 1-oxo-2-(3-piperidyl)-1,2,3,4- tetrahydroisoquinolines and related analogues as a new class of specific bradycardic agents possessing I(f) channel inhibitory activity.
Kubota H; Kakefuda A; Watanabe T; Ishii N; Wada K; Masuda N; Sakamoto S; Tsukamoto S
J Med Chem; 2003 Oct; 46(22):4728-40. PubMed ID: 14561092
[TBL] [Abstract][Full Text] [Related]
5. (+/-)-2-(3-Piperidyl)-1,2,3,4-tetrahydroisoquinolines as a new class of specific bradycardic agents.
Kubota H; Kakefuda A; Watanabe T; Taguchi Y; Ishii N; Masuda N; Sakamoto S; Tsukamoto Si
Bioorg Med Chem Lett; 2003 Jul; 13(13):2155-8. PubMed ID: 12798325
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and cardiovascular activity of phenylalkylamine derivatives. I. Potential specific bradycardic agents.
Ozaki F; Matsukura M; Kabasawa Y; Ishibashi K; Ikemori M; Hamano S; Minami N
Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2735-40. PubMed ID: 1464103
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.
Zhang X; Zhang J; Zhang L; Feng J; Xu Y; Yuan Y; Fang H; Xu W
Bioorg Med Chem; 2011 Oct; 19(20):6015-25. PubMed ID: 21911297
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel tetrahydroisoquinoline derivatives as potent and selective factor Xa inhibitors.
Ueno H; Yokota K; Hoshi J; Yasue K; Hayashi M; Uchida I; Aisaka K; Hase Y; Katoh S; Cho H
Bioorg Med Chem Lett; 2005 Jan; 15(1):185-9. PubMed ID: 15582437
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and cardiotonic activity of certain imidazo[2,1-b]-1,3,4-thiadiazole derivatives.
el-Sherbeny MA; el-Bendary ER; el-Subbagh HI; el-Kashef HA
Boll Chim Farm; 1997 Mar; 136(3):253-6. PubMed ID: 9164165
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of novel selective factor Xa inhibitors with a tetrahydroisoquinoline ring.
Ueno H; Yokota K; Hoshi J; Yasue K; Hayashi M; Hase Y; Uchida I; Aisaka K; Katoh S; Cho H
J Med Chem; 2005 May; 48(10):3586-604. PubMed ID: 15887966
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of novel substituted benzoylguanidine derivatives as potent Na+/H+ exchanger inhibitors.
Xu WT; Jin N; Xu J; Xu YG; Wang QJ; You QD
Bioorg Med Chem Lett; 2009 Jun; 19(12):3283-7. PubMed ID: 19433354
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacological evaluation of 1-isopropyl-1,2,3,4-tetrahydroisoquinoline derivatives as novel antihypertensive agents.
Watanuki S; Matsuura K; Tomura Y; Okada M; Okazaki T; Ohta M; Tsukamoto S
Chem Pharm Bull (Tokyo); 2011; 59(8):1029-37. PubMed ID: 21804249
[TBL] [Abstract][Full Text] [Related]
13. Novel milrinone analogs of pyridine-3-carbonitrile derivatives as promising cardiotonic agents.
Bekhit AA; Baraka AM
Eur J Med Chem; 2005 Dec; 40(12):1405-13. PubMed ID: 16040161
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists.
Naito R; Yonetoku Y; Okamoto Y; Toyoshima A; Ikeda K; Takeuchi M
J Med Chem; 2005 Oct; 48(21):6597-606. PubMed ID: 16220976
[TBL] [Abstract][Full Text] [Related]
15. Discovery of antiglioma activity of biaryl 1,2,3,4-tetrahydroisoquinoline derivatives and conformationally flexible analogues.
Mohler ML; Kang GS; Hong SS; Patil R; Kirichenko OV; Li W; Rakov IM; Geisert EE; Miller DD
J Med Chem; 2006 Sep; 49(19):5845-8. PubMed ID: 16970409
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antibacterial activity and QSAR studies of 1,2-disubstituted-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolines.
Tiwari RK; Singh D; Singh J; Chhillar AK; Chandra R; Verma AK
Eur J Med Chem; 2006 Jan; 41(1):40-9. PubMed ID: 16356593
[TBL] [Abstract][Full Text] [Related]
17. Closing in on the AMPA receptor: synthesis and evaluation of 2-acetyl-1-(4'-chlorophenyl)-6-methoxy-7-[11C]methoxy-1,2,3,4-tetrahydroisoquinoline as a potential PET tracer.
Arstad E; Gitto R; Chimirri A; Caruso R; Constanti A; Turton D; Hume SP; Ahmad R; Pilowsky LS; Luthra SK
Bioorg Med Chem; 2006 Jul; 14(14):4712-7. PubMed ID: 16621575
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of tetrahydroisoquinoline derivatives as potential multidrug resistance reversal agents in cancer.
Li Y; Zhang HB; Huang WL; Li YM
Bioorg Med Chem Lett; 2008 Jun; 18(12):3652-5. PubMed ID: 18502125
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and bioactivity of substituted indan-1-ylideneaminoguanidine derivatives.
Zhang R; Dong J; Xu YG; Hua WY; Wen N; You QD
Eur J Med Chem; 2009 Sep; 44(9):3771-6. PubMed ID: 19482383
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation on novel analogs of 9-methylstreptimidone, an inhibitor of NF-kappaB.
Ishikawa Y; Tachibana M; Matsui C; Obata R; Umezawa K; Nishiyama S
Bioorg Med Chem Lett; 2009 Mar; 19(6):1726-8. PubMed ID: 19231181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
